Abstract Extraordinary technological advances in DNA sequencing have greatly accelerated our ability to identify bacteria, at the species level, present in clinical samples taken from the human mouth. In addition, mass spectrometry has evolved such that oral samples can be analyzed for protein and metabolic products, providing insight into bacterial interaction with their human hosts in the maintenance of oral health or the onset of disease. The ability to cost-effectively determine the DNA sequence of individuals, accompanied by their unique microbiome, heralds the advent of personalized dental medicine.
Introductory Comments: the Advent of the Microbiome Era in Human Oral Biology
During his 2015 State of the Union address, President Obama announced an allocation of $215 million dollars to fund a Precision Medicine Initiative, to be driven by the National Institutes of Health, with the goal of developing the technology to prevent, diagnose, and treat diseases at the level of individual patients [1] . The elucidation and publication of the human genome in 2001 had initiated a new era in biology, one in which Bprecision medicine^became the concept on which the future of health care is being built. The foundation of precision medicine is the human genome and the genomes of the bacteria, viruses, fungi, and protists that are carried along on, and in, the human body and how those organisms relate to their hosts.
A series of Nobel Prize-winning discoveries was essential for establishing DNA sequences in the human genome and indeed the genome of all living things. The elucidation of DNA structure [2] ; its organization into groups, or Bcodons, of deoxyribonucleic acids that act as the translating chemicals between the structure of DNA and the amino acids that comprise proteins [3, 4] ; and, finally, deciphering the genetic code itself, showing that individual codons were specific for particular amino acids, thereby providing a basis for what is now thought of as biotechnology and genetic engineering [5] [6] [7] . Following the Nobel Prize-winning development, by Frederick Sanger in the 1970s, of a method to chemically determine the order of bases in a strand of DNA, referred to as BDNA sequencing^ [8] , it became a certainty that the genetic content-or genome-of all living things would be established.
The first sequence of the human genome, referred to as a draft sequence, was published in 2001 and constituted approx. 90 % of the genome [9] , at an estimated cost of $3 billion dollars (US). Thus, the first blueprint for human genomes was established, providing a known sequence on which additional human genomes, such as individual patients, could be mapped and compared, at the level of individual bases.
As the logical extension of the Human Genome project, the Human Microbiome Project (HMP) was launched in 2007, with the initial goal of establishing 3000 microbial genomes to serve as reference sequences for deep sequencing of samples from microbial communities, isolated from six regions of the human body: skin, mouth, esophagus, stomach, colon, and vagina [10] . The magnitude of the project was immediately clear, as it was already understood that bacterial cells alone outnumbered cells in the human body by approx. tenfold. Further, it was also understood, from the genetic content of known bacterial genomes, that the number of individual bacterial genes likely outnumbered human genes by an order of magnitude, at least.
Microbiomics of Dental Caries and Periodontal Disease-What Have We Learned?
Completion of the human genome project was accompanied by the parallel, and continuing, development of commercially available high-throughput DNA sequencing instruments, which have in turn facilitated the acquisition of genomic information from human oral samples. The majority of initial studies focused on identifying oral bacteria associated with health and disease. These types of studies relied on the use of 16S ribosomal RNA (rRNA)-encoding DNA as a target gene that can be used to identify and enumerate the number and kinds of bacteria in a given sample, including dental plaque samples and samples taken from periodontal pockets.
The results of a myriad B16S^studies culminated in the first publication of the Human Oral Microbiome Database (HOMD), which identified bacteria in samples taken from specific locations in the oral cavity: teeth, the gingival sulcus, tongue, cheek, hard and soft palates, and tonsils, all of which are colonized by bacteria [11] . HOMD represents, at least, 700 taxa, or bacteria, at the species level, as well as identified subsets of bacteria residing at different habitats. HOMD was the first curated database of a human microbiome, providing an essential, and continuously accumulating, database for comparison of oral bacterial genomic DNA sequences that continues to grow from ongoing studies.
Genome-sequencing protocols and instrumentation have evolved rapidly over the past decade, resulting in improvements in the amount of sequencing information that could be obtained from the relatively small, or limited, samples from the oral cavity. Moreover, the ability to obtain complete genome sequences from all bacteria in oral samples has made possible the field of meta-genomics: the ability to identify bacteria at the level of individual genes in complex samples.
What is now known from classical microbiological experiments, and from dramatically deeper information arising from metagenomic sequencing of oral plaque samples, is that specific bacteria are clearly associated with oral health and oral disease. Bacteria that have been associated with periodontal disease using advanced DNA sequencing approaches [12] fully support the results from classical microbiology data accumulated over several, earlier, decades [13, 14] , including the following species: Aggregatibacter actinomycetemcomitans, Fusobacterium nucleatum, Porphyromonas gingivalis, Prevotella intermedia, Tannerella forsythia, and Treponema denticola.
The bacterial genera that appeared at elevated levels in periodontal disease have included Campylobacter, Selenomonas, Deferribacteres, Dialister, Catonella, Tannerella, Streptococcus, Atopobium, Eubacterium, and Treponema [15] . Additional organisms, not well studied at the time but of strong recent interest, included Peptostreptococcus and Filifactor. Streptococcus and Veillonella were also found in high numbers in subjects with healthy periodontia, along with lower abundance organisms. What is also now fully realized is that human immune components, or lack thereof, and lifestyle attributes such as diet and smoking influence the composition and abundance of periodontal bacteria and the extent of periodontal disease, see for example [12, [15] [16] [17] [18] [19] .
The bacterial composition of supragingival plaque, associated with dental caries, has also been the object of sequencing studies [20, 21•, 22, 23] . Generally, streptococci associated with the well-known mutans group have been shown to dominate the bacterial composition of dental plaque associated with caries, though approx. 10 % of samples reveal absence or low abundance of Streptococcus mutans [21•, 22] . Veillonella species are also often found in substantial numbers associated with samples from carious lesions, suggesting that these bacteria facilitate dental caries. It is appreciated that the metabolism of Veillonella relies on the metabolism of lactic acid produced by streptococci, not just aciduric streptococci, such that its role in caries formation and progression is not entirely clear. However, it is clear that Veillonella is generally in high abundance in supragingival plaque samples containing streptococci.
In addition to identifying associations of bacteria with health and disease, the composite take-home message from the metagenomic studies reported to date can be simply stated: that periodontal disease and dental caries are complex diseases, reflecting changes in bacterial composition in disease sites, diet, and interface with the human immune system [24] . The available data strongly support the ecological hypothesis of Marsh, who, early on, opined that oral disease of bacterial etiology would reflect the environment, the bacteria, and the condition of the host [25, 26] . Changes in one or more of these components of a microbial niche may cause a potential pathobiont to become dominant, creating a dysbiotic or disease-favoring environment. Perhaps most interestingly, the microbial communities associated with dental caries show reduced diversity in the extent of microbial species [21•, 22] , whereas the periodontal disease pockets exhibit greater diversity [12, [27] [28] [29] , likely indicating that the availability of human cell constituents, crevicular fluid, and blood provide abundant substrates for growth of many bacterial species. Whereas on the tooth surfaces, erosion of enamel by bacteria is caused by prolonged exposure to organic acids, leading to localized pH values well below the limits of survival by many competing bacteria. S. mutans, as an example, can grow at pH values of 5 and continue to protect itself from acidification, via proton-pumping at pH values of 3.5 [30, 31] . That the acidogenic/aciduric species in the oral cavity can cause dental caries and survive the inimical influences of acidification, there is, in this era, no doubt.
The Rise of Meta-omics-the Connection of Microbiomes, Proteomes, and Metabolomes as Tools to Establish Health and Disease
The principal remaining questions in clinical oral microbiology revolve around how dysbiosis begins in the microbial niches of the oral cavity. However, over the last century, oral microbiology in the laboratory has consisted primarily of single-species cultures, with mixed-species experiments being utilized in a small number of laboratories. It is fully understood that the meta-genomes resident in the oral cavity represent health and the risk of disease. How that balance turns to disease is now being explored by the combination of multiple, technology-driven sciences: including the concepts of individual genomes, that is, determining the DNA sequence of all patients, along with a determination of all proteins present in disease sites, which represents the collective output of the bacteria at those sites, and most recently the science of metabolomics, which is the metabolic output of all bacteria in a given site. This would include, particularly in periodontal pockets, considerable amounts of biological material derived from the patient themselves. Proteomics is driven by ever more sensitive mass spectrometers to separate biological materials by mass, and to identify compounds by comparison to existing libraries of compounds and, to do so, in a quantitative manner. Likewise, metabolomics is also driven by mass spectrometric identification of bacterial, viral, fungal, and human products in disease sites. As the reader will rightly imagine, the application of these technologies to problems in oral biology would seem extremely complex. Nevertheless, the technologies continue to develop greater speed, precision, and depth at great rate, such that reports are now emerging that detail studies of mixes of bacteria, primarily model systems, that have been constructed to report on known bacteria. For example, the microbiota in salivary samples have been reported [32, 33] , underscoring the possibility that scientists and clinicians can use these technologies in a practical fashion to predict oral microbial disease. Specific interactions of P. gingivalis and Streptococcus, highly related to the onset of periodontal disease, are also being explored [34] [35] [36] . The combination of meta-genomics and metabolomics has recently been reported in studies with multiple oral bacterial species, in work designed to follow the development of bacterial products over time, as would be expected in healthy and disease sites [37•] . As impressive as the science has been, it is clear that the models and technologies are rapidly advancing, with their potential usefulness in personalized dental medicine now in the realm of the conceivable [28, 29, 38, 39] (Fig. 1) .
What Can We Still Learn from Microbiomic Information?
The metagenome of the oral cavity is comprised of hundreds of individual genomes. The most influential of these is arguably the human genome. Human genetic variation can influence phenotypes with obvious impacts on microbiome composition such as salivary flow rate, the composition of saliva, immune system function, and possibly taste preference [40] [41] [42] . Twin studies also suggested a genetic component to caries long before the human genome project was complete [43, 44] .
A thorough analysis of 93 individuals by Bleckhman et al. [45•] analyzed the correlation of host genetic profiles with specific species and microbiome alpha diversity at 15 body sites. Principal component analysis revealed a correlation between host genetic variation and alpha diversity in the supragingival plaque, the throat, and the tongue dorsum, suggesting genetics plays an especially important role in the diversity of the oral microbiome, compared to other body sites.
A pathway-based analysis was used to test associations between specific taxa and single-nucleotide polymorphisms (SNPs). The leptin signaling pathway had the most significant effect on microbiome composition. SNPs in leptin signaling were correlated with the presence of Lachnospiraceae and Haemophilus on the attached keratinized gingiva and Propionibacterium in subgingival plaque [45•] . Leptin is a hormone that influences many diverse metabolic functions including insulin secretion, appetite, inflammation, activation of leukocytes, and proliferation of oral keratinocytes [46, 47] . Other pathways correlated with specific taxa in the oral cavity including G protein signaling mediated by Tubby, P2Y purigenic receptor signaling, and melatonin signaling.
Finally, Blekhman et al. examined the variability of the taxa-associated SNPs between different human populations. They found that the allele frequency differentiation (measured by F ST ) of SNPs linked to specific taxa was significantly higher than the genome average [45•] . This increased variability suggests two possible scenarios: humans evolve adaptations in response to local, population-specific microbiomes or past defensive adaptations to specific pathogens are having a lasting effect on the present commensal microbiome. These two possibilities are not mutually exclusive. It is likely that examples of each can be found in our evolutionary history.
Many questions about humans' coevolution with their oral microbiome could be addressed by the emerging field of paleomicrobiology. The dental calculus can preserve bacterial DNA, mitochondrial DNA, and dietary fossils for thousands of years, giving us snapshots of ancient oral microbiomes [48] [49] [50] . There is currently not enough data in this field to address the subtleties of coevolution, but there is enough data to draw conclusions about the effects of major changes in the human diet. Consumption of cariogenic wild plants coincided with changes in the composition of the oral microbiota, including expansion of S. mutans in populations of Pleistocene hunter-gatherers [51] . European archaeological data sets show a major increase in the prevalence of dental caries and periodontitis coinciding with the introduction of farming in the Neolithic period [52] . Another marked increase in the prevalence of dental caries occurred in the mid-nineteenth century, during the industrial revolution [53] . DNA evidence suggests that during both of these time periods, overall diversity in the oral microbiome decreased, and the prevalence of S. mutans increased [54] . Neolithic farming is also associated with a significant increase in the prevalence of P. gingivalis [54] . Warinner et al. [50] sampled dental calculus from human skeletons with evidence of periodontal disease buried between 950 and 1200 CE in Dalheim, Germany. Sequencing 16S rRNA revealed an abundance of T. forsythia, P. gingivalis, and T. denticola, three species commonly associated with modern periodontitis [55] . These findings provide strong evidence in favor of the ecological theory of caries, which suggests that changes in carbohydrate intake affect the ecosystem of the mouth. Increases in carbohydrate intake in the modern era, resulting from the consumption of processed grains, favor pathogenic ecologies [25, 56] .
One of the main goals of the Human Microbiome Project is to find differences between microbiome compositions in healthy and diseased states [57] . Because of the unique nature of every person's microbiome, it may be many years before we can clearly define what it means to have a Bhealthy^oral bacterial community. As our knowledge in this area becomes more complete, what clinical benefits will we gain?
Knowledge of microbiomes, in general, is not enough. For any patient-oriented applications, we must develop technology to make regular monitoring of a patient's oral microbiome practical. Based on the progress of DNA sequencing technologies in the past 20 years, there is no reason to doubt that this technology will eventually exist.
Testing for the simple presence or absence of bacterial species is probably not a practical way to screen for the risk of caries or periodontitis. These are multifactorial diseases that do not depend on any one pathogenic species [12] . There are some opportunistic pathogens, however, that maintain a reservoir in the oral microbiome and cause infections outside of the oral cavity [58] . Infective endocarditis is often the result of oral bacteria entering the bloodstream [58, 59] . There is an ongoing debate about the efficacy of providing prophylactic antibiotics to patients undergoing dental procedures that are at heightened risk for endocarditis [60] [61] [62] . Perhaps a more accurate risk assessment could be made by testing each patient for the presence of species (or serotypes) that have been known to cause infective endocarditis [63, 64] . Similarly, nosocomial pneumonia is correlated with periodontitis and poor oral health [65, 66] . Screening the oral microbiome for respiratory pathogens may help assess a patient's risk of developing pneumonia while in the hospital.
Disease prevention is always preferable to disease treatment, so how could information about a patient's microbiome be used to predict the risk of caries or periodontitis? If there are distinct healthy and diseased microbiomes for the teeth and gums, then there must also be transitional states. Some research has been done regarding transitional states in the gut If plaque has accumulated, or at regular check-up (depending on cost)
Not yet clear which -omic technique will be most informaƟve
Dietary changes and educaƟon ProbioƟc bacteria
Targeted anƟbioƟcs or other small molecules BioinformaƟc Analysis Fig. 1 Possible analysis and treatment options for future dentists and clinicians. This flow chart represents a potential new paradigm for observing and treating oral diseases with a microbiological component. The specific technique that will be most helpful for assessing disease risk and treatment options is not yet known (blue box). All of these techniques will require significant advances in technology and years of clinical study before becoming practical and lungs, but the concept is mostly speculation [67, 68] . Are transitional states somewhere on a spectrum between health and illness, or are there species that play an important role in the transition without being prevalent in either health or disease? How long do transitional states last? As these questions are answered, we may gain a tool for predicting the onset of caries or periodontitis long before any visible signs of demineralization or inflammation occur.
If a disease is already severe, understanding the patient's microbiome could still be beneficial. The number of species combinations in the microbiome that could be considered unhealthy is potentially infinite. The best treatment for a case of periodontitis dominated by P. gingivalis and T. denticola may be different from the best treatment for periodontitis dominated by P. gingivalis and T. forsythia. The complex interactions between multiple species are known to influence the effectiveness of antibiotics [69] . Future research will provide more definite insight into increasing the specificity of treatments.
One significant problem with finding the best treatments for specific microbiome maladies is our current lack of narrow-spectrum antibiotics. Broad-spectrum antibiotics have saved millions of lives, but side effects from their disruption to the normal microbiome can be devastating, especially in the gut [70, 71] . The knowledge of healthy versus unhealthy microbiomes will not be very useful to patients if we lack the ability to manipulate their microbiome composition. This problem could possibly be solved using narrow-spectrum antibiotics; however, the antibiotics currently available are most likely not specific enough to produce the desired effects. This is especially true for dental caries, where different species from the same genus, Streptococcus, have been shown to contribute to caries and also prevent them [12, 24] . Fecal transplantation has been shown to effectively alter the microbiome of the gut [72, 73] , but this method would be very difficult to implement in the oral cavity. The salivary flow and normal use of the mouth complicate the delivery of the new microbiome, and pre-established biofilms on enamel surfaces inhibit colonization by new species and are difficult to remove [69, 74] . Bacteriocins, antibiotic peptides produced by bacteria, are a potential new class of narrow-spectrum antibiotics [75, 76] . They can have very specific targets, but may be difficult to produce and administer [77] .
The best way to deliver bacteriocins may be via whole, living bacteria. Probiotics as a method for improving oral health have been heavily researched [78] [79] [80] , there is even a method for using meta-genomics to screen for potential probiotics [24] , but no definite conclusions have been made regarding future treatments. Biofilms may prevent a complete change in microbiome, but research has found several specific species that are able to infiltrate established dental biofilms [78] . If these species could be engineered to produce bacteriocins, the target species could be eliminated and prevented from returning, the process being dependent on the continued presence of the probiotic species. There are many other helpful products besides bacteriocins that could be produced by engineered probiotics. Overproduction of natural metabolic products like ammonia-containing compounds (to increase pH) or peroxide (for oxidative stress) could alter the environment, and therefore the microbiome, in a positive way [81] .
It has been argued that observing the prevalent metabolic pathways in the oral microbiome could be more important than observing the species [82] . This requires sequencing all of the DNA or RNA present, as opposed to only small sections of 16S rRNA, but it may be more useful as a diagnostic tool. For many bacterial species in the oral cavity, the 16S sequence is the only thing known about them, so the effect of their presence is currently unknown. If the major metabolic pathways present in a microbiome are known, it should be easier to predict how that microbiome will react to different environmental perturbations. Potentially informative pathways include antibiotic resistance mechanisms, lactic acid fermentation, short-chain fatty acid production [83] , and many more. Perhaps future microbiologists will be able to discuss microbiomes in terms of their ability to lower pH or induce inflammation without much knowledge of the species involved.
What can we learn from the human oral microbiome project? Like any other large research undertaking, every answer provides us with new questions. Knowledge of the oral microbiome is driving research in new directions, many of which do not rely on large-scale DNA sequencing. Experiments using live cells are especially important for conducting experiments that depend on specific spatial or temporal arrangements of bacteria, such as adherence to enamel. He et al. [74] identified a specific Bsocial structure^of three species from the mouse oral microbiome that synergistically cooperate to inhibit the colonization by Escherichia coli. Staphylococcus saprophyticus senses the E. coli LPS and produces a diffusible signal that directly increases peroxide production by Streptococcus sanguinis. S. saprophyticus also disrupts the ability of Streptococcus infantis to inhibit peroxide production by S. sanguinis.
There are hundreds, maybe thousands, of polymicrobial interactions like the one described by He simultaneously occurring in the microbiome, and they are subtly different for every individual. Here, the main examples focused on bacteria, but fungi and viruses are important components of the microbiome, each with their own unique metabolic contributions. Organizing this vast amount of information has become a science in its own right [84, 85] . Bioinformatics is already indispensable and will grow in importance as more data is gathered. Public databases such as the National Center for Biotechnology Information (NCBI) and HOMD represent the principal, major resources for gaining an understanding of the oral microbiome [86] . Microbiomes are as unique as a fingerprint, but common patterns will have to be found, and studied, using large data sets gathered from many individuals.
